These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 39013412

  • 1. Incretin-mediated control of cardiac energy metabolism.
    Chan JSF, Shafaati T, Ussher JR.
    J Endocrinol; 2024 Oct 01; 263(1):. PubMed ID: 39013412
    [Abstract] [Full Text] [Related]

  • 2. Diabetes and obesity treatment based on dual incretin receptor activation: 'twincretins'.
    Skow MA, Bergmann NC, Knop FK.
    Diabetes Obes Metab; 2016 Sep 01; 18(9):847-54. PubMed ID: 27160961
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Targeting the GIPR for obesity: To agonize or antagonize? Potential mechanisms.
    Campbell JE.
    Mol Metab; 2021 Apr 01; 46():101139. PubMed ID: 33290902
    [Abstract] [Full Text] [Related]

  • 6. Incretin hormones and type 2 diabetes.
    Nauck MA, Müller TD.
    Diabetologia; 2023 Oct 01; 66(10):1780-1795. PubMed ID: 37430117
    [Abstract] [Full Text] [Related]

  • 7. The dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist tirzepatide: a novel cardiometabolic therapeutic prospect.
    Fisman EZ, Tenenbaum A.
    Cardiovasc Diabetol; 2021 Nov 24; 20(1):225. PubMed ID: 34819089
    [Abstract] [Full Text] [Related]

  • 8. GLP-1 and GIP receptor signaling in beta cells - A review of receptor interactions and co-stimulation.
    Mayendraraj A, Rosenkilde MM, Gasbjerg LS.
    Peptides; 2022 May 24; 151():170749. PubMed ID: 35065096
    [Abstract] [Full Text] [Related]

  • 9. Structural determinants of dual incretin receptor agonism by tirzepatide.
    Sun B, Willard FS, Feng D, Alsina-Fernandez J, Chen Q, Vieth M, Ho JD, Showalter AD, Stutsman C, Ding L, Suter TM, Dunbar JD, Carpenter JW, Mohammed FA, Aihara E, Brown RA, Bueno AB, Emmerson PJ, Moyers JS, Kobilka TS, Coghlan MP, Kobilka BK, Sloop KW.
    Proc Natl Acad Sci U S A; 2022 Mar 29; 119(13):e2116506119. PubMed ID: 35333651
    [Abstract] [Full Text] [Related]

  • 10. Human epicardial adipose tissue expresses glucose-dependent insulinotropic polypeptide, glucagon, and glucagon-like peptide-1 receptors as potential targets of pleiotropic therapies.
    Malavazos AE, Iacobellis G, Dozio E, Basilico S, Di Vincenzo A, Dubini C, Menicanti L, Vianello E, Meregalli C, Ruocco C, Ragni M, Secchi F, Spagnolo P, Castelvecchio S, Morricone L, Buscemi S, Giordano A, Goldberger JJ, Carruba M, Cinti S, Corsi Romanelli MM, Nisoli E.
    Eur J Prev Cardiol; 2023 Jun 01; 30(8):680-693. PubMed ID: 36799940
    [Abstract] [Full Text] [Related]

  • 11. The GIP receptor displays higher basal activity than the GLP-1 receptor but does not recruit GRK2 or arrestin3 effectively.
    Al-Sabah S, Al-Fulaij M, Shaaban G, Ahmed HA, Mann RJ, Donnelly D, Bünemann M, Krasel C.
    PLoS One; 2014 Jun 01; 9(9):e106890. PubMed ID: 25191754
    [Abstract] [Full Text] [Related]

  • 12. Loss of GIPR in LEPR cells impairs glucose control by GIP and GIP:GLP-1 co-agonism without affecting body weight and food intake in mice.
    Akindehin S, Liskiewicz A, Liskiewicz D, Bernecker M, Garcia-Caceres C, Drucker DJ, Finan B, Grandl G, Gutgesell R, Hofmann SM, Khalil A, Liu X, Cota P, Bakhti M, Czarnecki O, Bastidas-Ponce A, Lickert H, Kang L, Maity G, Novikoff A, Parlee S, Pathak E, Schriever SC, Sterr M, Ussar S, Zhang Q, DiMarchi R, Tschöp MH, Pfluger PT, Douros JD, Müller TD.
    Mol Metab; 2024 May 01; 83():101915. PubMed ID: 38492844
    [Abstract] [Full Text] [Related]

  • 13. The Effects of Dual GLP-1/GIP Receptor Agonism on Glucagon Secretion-A Review.
    Mathiesen DS, Bagger JI, Bergmann NC, Lund A, Christensen MB, Vilsbøll T, Knop FK.
    Int J Mol Sci; 2019 Aug 22; 20(17):. PubMed ID: 31443356
    [Abstract] [Full Text] [Related]

  • 14. Pharmacological characterization of mono-, dual- and tri-peptidic agonists at GIP and GLP-1 receptors.
    Yuliantie E, Darbalaei S, Dai A, Zhao P, Yang D, Sexton PM, Wang MW, Wootten D.
    Biochem Pharmacol; 2020 Jul 22; 177():114001. PubMed ID: 32360365
    [Abstract] [Full Text] [Related]

  • 15. Enhanced Endosomal Signaling and Desensitization of GLP-1R vs GIPR in Pancreatic Beta Cells.
    Manchanda Y, Bitsi S, Chen S, Broichhagen J, Bernardino de la Serna J, Jones B, Tomas A.
    Endocrinology; 2023 Mar 13; 164(5):. PubMed ID: 36774542
    [Abstract] [Full Text] [Related]

  • 16. Glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide stimulate release of substance P from TRPV1- and TRPA1-expressing sensory nerves.
    Mayer F, Gunawan AL, Tso P, Aponte GW.
    Am J Physiol Gastrointest Liver Physiol; 2020 Jul 01; 319(1):G23-G35. PubMed ID: 32421358
    [Abstract] [Full Text] [Related]

  • 17. Regulation of energy metabolism through central GIPR signaling.
    Liskiewicz A, Müller TD.
    Peptides; 2024 Jun 01; 176():171198. PubMed ID: 38527521
    [Abstract] [Full Text] [Related]

  • 18. Two incretin hormones GLP-1 and GIP: comparison of their actions in insulin secretion and β cell preservation.
    Yabe D, Seino Y.
    Prog Biophys Mol Biol; 2011 Nov 01; 107(2):248-56. PubMed ID: 21820006
    [Abstract] [Full Text] [Related]

  • 19. Differential effects of glucose-dependent insulinotropic polypeptide receptor/glucagon-like peptide-1 receptor heteromerization on cell signaling when expressed in HEK-293 cells.
    Al-Zaid B, Chacko S, Ezeamuzie CI, Bünemann M, Krasel C, Karimian T, Lanzerstorfer P, Al-Sabah S.
    Pharmacol Res Perspect; 2022 Oct 01; 10(5):e01013. PubMed ID: 36177761
    [Abstract] [Full Text] [Related]

  • 20. Effects of gastric inhibitory polypeptide, glucagon-like peptide-1 and glucagon-like peptide-1 receptor agonists on Bone Cell Metabolism.
    Hansen MSS, Tencerova M, Frølich J, Kassem M, Frost M.
    Basic Clin Pharmacol Toxicol; 2018 Jan 01; 122(1):25-37. PubMed ID: 28722834
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.